Envoy Medical (COCH) Change in Accured Expenses (2021 - 2026)

Envoy Medical has disclosed Change in Accured Expenses across 6 years of filings, most recently posting $664000.0 for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at $664000.0, up 233.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 9.88% YoY), and the FY2025 annual result was $839000.0, down 5.84% from the prior year.
• Change in Accured Expenses came in at $664000.0 for Q1 2026 at Envoy Medical, up from $623000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $1.3 million in Q3 2024 to a low of -$982000.0 in Q2 2024.
• The 5-year median for Change in Accured Expenses is $199000.0 (2025), against an average of $143117.6.
• Across the five-year window, Change in Accured Expenses soared 4102.27% in 2022 and slumped 432.49% in 2023, its largest moves.
• Envoy Medical's Change in Accured Expenses stood at $237000.0 in 2022, then plunged by 432.49% to -$788000.0 in 2023, then soared by 217.64% to $927000.0 in 2024, then plunged by 32.79% to $623000.0 in 2025, then climbed by 6.58% to $664000.0 in 2026.
• The last three Change in Accured Expenses figures came in at $664000.0 (Q1 2026), $623000.0 (Q4 2025), and -$96000.0 (Q3 2025), per Business Quant data.